NCT03363178View on ClinicalTrials.gov

Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Tuberculosis
Interventions
BIOLOGICAL

GC3107

BCG Vaccine, 0.1mL

Trial Locations (1)

Unknown

RECRUITING

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY